diltiazem has been researched along with vecuronium bromide in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Kampine, JP; Schmeling, WT; Warltier, DC | 1 |
| Arai, T; Nagaro, T; Naruoka, Y; Ochi, G; Shimizu, C; Takasaki, Y | 1 |
| Makita, K; Saitoh, Y; Tanaka, H | 1 |
| Fujii, Y; Saitoh, Y; Takahashi, S; Toyooka, H | 1 |
3 trial(s) available for diltiazem and vecuronium bromide
| Article | Year |
|---|---|
[Diltiazem potentiates the neuromuscular blockade by vecuronium in humans].
Topics: Adult; Aged; Anesthesia, General; Diltiazem; Drug Synergism; Female; Humans; Infusions, Intravenous; Isoflurane; Male; Middle Aged; Neuromuscular Junction; Vecuronium Bromide | 1995 |
Diltiazem and vecuronium: neuromuscular and cardiovascular effects.
Topics: Adult; Anesthetics, Intravenous; Blood Pressure; Calcium Channel Blockers; Diltiazem; Heart Rate; Humans; Intubation, Intratracheal; Neuromuscular Blockade; Neuromuscular Nondepolarizing Agents; Thiopental; Time Factors; Vecuronium Bromide | 1997 |
Diltiazem-lidocaine combination for the attenuation of cardiovascular responses to tracheal intubation in hypertensive patients.
Topics: Aged; Anesthetics, Intravenous; Anti-Arrhythmia Agents; Antihypertensive Agents; Blood Pressure; Diltiazem; Double-Blind Method; Drug Combinations; Female; Heart Rate; Humans; Hypertension; Injections, Intravenous; Intubation, Intratracheal; Laryngoscopy; Lidocaine; Male; Middle Aged; Neuromuscular Depolarizing Agents; Neuromuscular Nondepolarizing Agents; Succinylcholine; Thiopental; Vecuronium Bromide | 1998 |
4 other study(ies) available for diltiazem and vecuronium bromide
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Negative chronotropic actions of sufentanil and vecuronium in chronically instrumented dogs pretreated with propranolol and/or diltiazem.
Topics: Analgesics; Animals; Diltiazem; Dogs; Drug Interactions; Electrocardiography; Fentanyl; Heart Rate; Hemodynamics; Naloxone; Propranolol; Sufentanil; Vecuronium Bromide | 1989 |